Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 66,801 bioRxiv papers from 294,138 authors.

Tumors subvert immune cell function to evade immune responses, and the mechanisms of tumor immune evasion are incompletely understood. Here we show that tumors induce de novo steroidogenesis in T lymphocytes to evade anti-tumor immunity. Using a novel transgenic fluorescent reporter mouse line we identify and characterize de novo steroidogenic T cells. Genetic ablation of T cell steroidogenesis restricts primary tumor growth and metastatic dissemination in mouse models. Steroidogenic T cells dysregulate anti-tumor immunity, which can be restored by inhibiting the steroidogenesis pathway. This study demonstrates that T cell de novo steroidogenesis is a cause of anti-tumor immunosuppression and a druggable target.

Download data

  • Downloaded 551 times
  • Download rankings, all-time:
    • Site-wide: 18,472 out of 66,801
    • In immunology: 333 out of 1,701
  • Year to date:
    • Site-wide: 14,984 out of 66,801
  • Since beginning of last month:
    • Site-wide: 8,514 out of 66,801

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News